Abbott Laboratories (NYSE:ABT) is included among the Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit.
On June 17, Citi reiterated its Buy rating on Abbott Laboratories. It said that the company’s individual businesses may be worth more than the market currently values the company as a whole. According to the firm’s sum-of-the-parts analysis, Abbott’s shares could be worth between $99 and $104, compared with the current share price of about $89. The analyst said in a research note that easing headwinds and the company’s pipeline of new products could help reverse the recent pressure on the stock.
On June 12, BofA lowered its price recommendation on Abbott to $102 from $120. It reiterated a Buy rating on the stock. Analyst Travis Steed noted that the firm’s services team continues to see a lower utilization environment. As a result, he is taking a more conservative approach to 2027 estimates for medtech companies, particularly since current valuations already reflect utilization-related risks. The analyst also assumes inflation will create more challenges in 2027, leading to less margin expansion across the medtech sector. Based on those assumptions, BofA reduced its 2027 estimates for several large-cap companies in its coverage universe that have exposure to utilization trends and inflation.
Abbott Laboratories is a global healthcare company focused on the discovery, development, manufacture, and sale of a broad range of healthcare products.
READ NEXT: 12 Stocks From Companies Generating High Cash Flow and 12 Stocks with Highest Dividend to Invest In Now